Retour au portail Europarl

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (sélectionné)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Ce document n'est pas disponible dans votre langue et vous est proposé dans une autre langue parmi celles disponibles dans la barre des langues.

Parliamentary questions
8 December 2017
E-007590-17
Question for written answer
to the Commission
Rule 130
Stanisław Ożóg (ECR) , Zbigniew Kuźmiuk (ECR) , Valdemar Tomaševski (ECR)

 Subject:  Introduction of a ban on trans-unsaturated fatty acids
 Answer(s) 

The US Food and Drug Administration has ordered a halt on the production of trans‐unsaturated fatty acids. Its justification is that hydrogenated vegetable fats are bad for consumer health: they raise levels of bad cholesterol and reduce the concentration of good cholesterol, increase the risk of a number of serious cardiovascular diseases (cardiac arrest and circulatory failure), can lead to type 2 diabetes and may even increase the risk of cancer.

A ban on these fats could decrease the number of deaths caused by heart attack or other cardiovascular diseases, and could also lower rates of type 2 diabetes.

In light of the above, is the Commission considering the feasibility of introducing a ban on the use of trans-unsaturated fatty acids in the EU on health grounds, as has already been done in Denmark, for example?

Original language of question: PL 
Dernière mise à jour: 4 janvier 2018Avis juridique